Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors

Author： Wolter Pascal Beuselinck Benoit Pans Steven Schoffski Patrick

ISSN： 0284-186X

Source： Acta Oncologica, Vol.48, Iss.4, 2009-05, pp. : 621-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors in Pediatric Malignancies

By Skolnik Jeffrey Adamson Peter

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 606-612

Informa Healthcare

Access to resources Recommend Favorite

Cardiotoxicity induced by tyrosine kinase inhibitors

By Orphanos George Ioannidis George Ardavanis Alexandros

Acta Oncologica, Vol. 48, Iss. 7, 2009-10 ,pp. : 964-970

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of Quinazolines as Tyrosine Kinase Inhibitors

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 246-275

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite